Mechanical unloading increases caveolin expression in the failing human heart

Cardiovascular Research

Volumn 59, Issue 1, 2003, Pages 57-66

  Uray, Iván P ^a   Connelly, John H ^b   Frazier, O Howard ^c   Taegtmeyer, Heinrich ^a   Davies, Peter J A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS HEART INSTITUTE   (United States)

Author keywords

Cardiomyopathy; Gene expression; Heart failure; Remodeling; Transplantation

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CAVEOLIN 1; CAVEOLIN 3; CD36 ANTIGEN; FORMALDEHYDE; ISOPROTEIN; MESSENGER RNA;

ADULT; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART ASSIST DEVICE; HEART FAILURE; HEART FUNCTION; HEART MUSCLE; HEART TRANSPLANTATION; HEART WORK; HORMONE DETERMINATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMPLANTATION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SARCOLEMMA; UPREGULATION; WESTERN BLOTTING;

ADULT; ANTIGENS, CD36; ATRIAL NATRIURETIC FACTOR; BLOTTING, WESTERN; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CAVEOLINS; CLUSTER ANALYSIS; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0038143247     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(03)00352-3     Document Type: Article

References (30)

1. Barbone A., Holmes J.W., Heerdt P.M., The A.H., Naka Y., et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation. 104:2001;670-675.
2. Heerdt P.M., Holmes J.W., Cai B., Barbone A., Madigan J.D., et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation. 102:2000;2713-2719.
3. MacKenna D., Summerour S.R., Villarreal F.J. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc Res. 46:2000;257-263.
4. Li Y.Y., Feng Y., McTiernan C.F., Pei W., Moravec C.S., et al. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation. 104:2001;1147-1152.
5. Birks E.J., Latif N., Owen V., Bowles C., Felkin L.E., et al. Quantitative myocardial cytokine expression and activation of the apoptotic pathway in patients who require left ventricular assist devices. Circulation. 104:2001;I233-240.
6. Uray I.P., Connelly J.H., Thomazy V., Shipley G.L., Vaughn W.K., et al. Left ventricular unloading alters receptor tyrosine kinase expression in the failing human heart. J Heart Lung Transplant. 21:2002;771-782.
7. Lisanti M.P., Scherer P.E., Vidugiriene J., Tang Z., Hermanowski-Vosatka A., et al. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J Cell Biol. 126:1994;111-126.
8. Fujita T., Toya Y., Iwatsubo K., Onda T., Kimura K., et al. Accumulation of molecules involved in alpha1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy. Cardiovasc Res. 51:2001;709-716.
9. Rybin V.O., Xu X., Lisanti M.P., Steinberg S.F. Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem. 275:2000;41447-41457.
10. Li S., Couet J., Lisanti M.P. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem. 271:1996;29182-29190.
11. Scherer P.E., Lewis R.Y., Volonte D., Engelman J.A., Galbiati F., et al. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J Biol Chem. 272:1997;29337-29346.
12. Woodman S.E., Park D.S., Cohen A.W., Cheung M., Chandra M., et al. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAP kinase cascade. J Biol Chem. 277:(41):2002;38988-38997.
13. Park D.S., Woodman S.E., Schubert W., Cohen A.W., Frank P.G., et al. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype. Am J Pathol. 160:2002;2207-2217.
14. Shi Y., Pritchard K.A. Jr., Holman P., Rafiee P., Griffith O.W., et al. Chronic myocardial hypoxia increases nitric oxide synthase and decreases caveolin-3. Free Rad Biol Med. 29:2000;695-703.
15. Oka N., Asai K., Kudej R.K., Edwards J.G., Toya Y., et al. Downregulation of caveolin by chronic beta-adrenergic receptor stimulation in mice. Am J Physiol. 273:1997;C1957-1962.
16. Nikolaidis L.A., Hentosz T., Doverspike A., Huerbin R., Stolarski C., et al. Catecholamine stimulation is associated with impaired myocardial O(2) utilization in heart failure. Cardiovasc Res. 53:2002;392-404.
17. Hare J.M., Lofthouse R.A., Juang G.J., Colman L., Ricker K.M., et al. Contribution of caveolin protein abundance to augmented nitric oxide signaling in conscious dogs with pacing-induced heart failure. Circ Res. 86:2000;1085-1092.
18. Brinkmann J.F., Abumrad N.A., Ibrahimi A., Van Der Vusse G.J., Glatz J.F. New insights in long-chain fatty acid uptake by heart muscle: crucial role for FAT/CD36. Biochem J. 367:2002;561-570.
19. Ogletree-Hughes M.L., Stull L.B., Sweet W.E., Smedira N.G., McCarthy P.M., et al. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation. 104:2001;881-886.
20. Heerdt P.M., Schlame M., Jehle R., Barbone A., Burkhoff D., et al. Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device. Ann Thorac Surg. 73:2002;1216-1221.
21. Frazier O.H., Macris M.P., Myers T.J., Duncan J.M., Radovancevic B., et al. Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg. 57:1994;1416-1422. discussion 1421-1422.
22. Dickstein K., Aarsland T., Hall C. Plasma N-terminal atrial natriuretic factor: a predictor of survival in patients with congestive heart failure. J Card Fail. 3:1997;83-89.
23. Zierhut W., Studer R., Laurent D., Kastner S., Allegrini P., et al. Left ventricular wall stress and sarcoplasmic reticulum Ca(2+)-ATPase gene expression in renal hypertensive rats: dose-dependent effects of ACE inhibition and AT1-receptor blockade. Cardiovasc Res. 31:1996;758-768.
24. Milting H., A E.L.B., Kassner A., Fey O., Sarnowski P., et al. The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types. J Heart Lung Transplant. 20:2001;949-955.
25. Razeghi P., Mukhopadhyay M., Myers T.J., Williams J.N., Moravec C.S., et al. Myocardial tumor necrosis factor-alpha expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support. Ann Thorac Surg. 72:2001;2044-2050.
26. Young L.H., Ikeda Y., Lefer A.M. Caveolin-1 peptide exerts cardioprotective effects in myocardial ischemia-reperfusion via nitric oxide mechanism. Am J Physiol Heart Circ Physiol. 280:2001;H2489-2495.
27. Ostrom R.S., Gregorian C., Drenan R.M., Xiang Y., Regan J.W., et al. Receptor number and caveolar co-localization determine receptor coupling efficiency to adenylyl cyclase. J Biol Chem. 31:2001;31.
28. Aitman T.J., Glazier A.M., Wallace C.A., Cooper L.D., Norsworthy P.J., et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet. 21:1999;76-83.
29. Nozaki S., Tanaka T., Yamashita S., Sohmiya K., Yoshizumi T., et al. CD36 mediates long-chain fatty acid transport in human myocardium: complete myocardial accumulation defect of radiolabeled long-chain fatty acid analog in subjects with CD36 deficiency. Mol Cell Biochem. 192:1999;129-135.
30. Hajri T., Ibrahimi A., Coburn C.T., Knapp F.F. Jr., Kurtz T., et al. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J Biol Chem. 276:2001;23661-23666.